Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • FEBRUARY 2021 Issue has been successfully launched on 1 February 2021.



Ashok Kumar Sharma*, Dr. Vandana Sharma, Dr. Gyanendra Singh, Mukesh Sharma and Subhash Chand Pingolia


The main aim of the anticancer drugs is to eradicate the presence of malignant cells. The anticancer drugs are classified on the bases of their site of action on a point of biosynthesis pathway of important bio molecules. These classified as follows Alkylating agents, cytotoxic antibiotics, Anti metabolites, Microtubules inhibitors, and one of the advanced agents is the Osmium compounds. FY-26 is the extremely potent anticancer drug which acts as shutdown the cancer cells by exploiting weakness inherent in their energy generation. On the bases of research activity the parameters recorded that anticancer activity of FY- 26 is 49 times more potent than that of cisplatin. The results (Data) were obtained by National Cancer Institute USA in a tests conducted on 60 cell lines. Cancer cells are able to use their defective mitochondria for metabolic activity in their cytoplasm to generate energy, but the potent drug FY-26 inhibits their activity of generating energy, which causes the cancer cells to die. Mitochondria are the mini-power house for the cells. The power house of the cell (mitochondria) in cancer cells is mostly defective and as such they cannot produce sufficient energy for their growth.

Keywords: The main aim more potent than that of cisplatin.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More